Email Updates

You are here

AVAC in the News

  • This week, the World Health Assembly (WHA), the governing body of the World Health Organization, is grappling with how best to prepare for and ideally prevent future pandemics. The WHA is taking as its starting point recommendations from the Independent Panel for Pandemic Preparedness and Response, which issued its findings earlier this month. The report is toothier and more specific than prior comparable commissions but has also generated debate over if and how to create a global governing body for pandemic action.

    May 30, 2021
    Foreign Policy
  • Tuesday, May 18, marks HIV Vaccine Awareness Day (#HVAD) 2021. It’s designated as a time to thank the researchers, community leaders, health professionals and volunteers working to develop a vaccine to prevent HIV/AIDS. It’s also a day to educate the public about advancements in vaccine research and raise awareness about the need for an HIV vaccine.

    May 18, 2021
  • The way in which the world has responded to COVID, has fundamentally changed ideas of what’s possible in vaccine development—but, regrettably, access to that scientific knowledge remains the property of a few drug companies and research institutions in wealthy countries.

    May 18, 2021
  • First celebrated in 1998, a little more than a decade after the launch of the very first HIV vaccine study, HIV Vaccine Awareness Day (HVAD), observed each May 18, is an opportunity to spotlight the ongoing global efforts to develop a safe and effective vaccine against HIV.

    May 18, 2021
    HIV Plus Mag
  • America led the world in buying up the messenger RNA vaccines that have proven most effective against COVID-19. It’s now starting to lead the world in not using them.

    May 15, 2021
  • In a little under a year, scientists developed several vaccines against COVID-19. But as we line up for our shots, we are still living in the shadow of another pandemic. The search for a vaccine against HIV, the virus that causes AIDS, has been ongoing for nearly four decades. To this day, only one large-scale trial has demonstrated even marginal efficacy at preventing infection from the virus: the RV144 trial in Thailand—the largest HIV vaccine trial in history.

    May 8, 2021
    JSTOR Daily
  • A Non-Governmental Organisation (NGO), Heartland Alliance, has expressed worry about the alarming HIV infections in Nigeria, currently at 100,000 per day. Mr. Michael Akanji, a resource person, speaking at a media roundtable organised by the NGO and the AVAC 2020/2021 Fellowship Programme at the weekend in Uyo, Akwa Ibom State, decried the continued high rating of Akwa Ibom in HIV Prevalence Rating in the country.

    May 3, 2021
    The Nation
  • The COVID-19 pandemic has lasted only slightly more than a year; the AIDS epidemic, by contrast, now spans decades. Just as AIDS has taken more than 670,000 lives in this country, scientists have long dreamed of a day when they could inoculate the population against HIV, the virus which causes the deadly disease.

    April 9, 2021
  • In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN 702, or Uhambo, was halted for lack of efficacy. Researchers and advocates had high hopes for Uhambo, building as it did on the RV144 trial, which provided the first evidence that an HIV vaccine could create a partially protective immune response. But Uhambo, like several studies before it, ended in disappointment.

    April 7, 2021
    Science Speaks
  • In the shut-down world of COVID-19, medical science conferences take place virtually—and protests do, too. Such was the case this week during the Conference on Retroviruses and Opportunistic Infections (CROI 2021), which from March 6 to March 10 featured breaking, clinically important research on HIV and the novel coronavirus.

    March 11, 2021
    The BodyPro